|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|
| Assets: | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Cash and marketable securities held in Trust Account | ||||
| Deferred offering costs | ||||
| Cash and marketable securities held in Trust Account | ||||
| Total assets | ||||
| Liabilities, Redeemable Ordinary Shares and Shareholders’ Deficit | ||||
| Accrued offering costs and expenses | ||||
| Promissory Note - Related Party | ||||
| Due to related party | ||||
| Total current liabilities | ||||
| Deferred underwriters’ fee | ||||
| Total liabilities | ||||
| Redeemable Ordinary Shares | ||||
| Class A ordinary shares subject to possible redemption, 14,375,000 Class A ordinary shares at redemption value of $10.20 per share at March 31, 2022 and December 31, 2021 | ||||
| Shareholders’ Deficit: | ||||
| Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 143,750 shares issued and outstanding (excluding 14,375,000 shares subject to redemption) at March 31, 2022 and December 31, 2021 | ||||
| Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 3,593,750 shares issued and outstanding as of March 31, 2022 and December 31, 2021 | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| Total Liabilities, Redeemable Ordinary Shares and Shareholders’ Deficit |
Loading...
